Putting Semantic Web Ideas to Work



IO Informatics uses the Semantic Web to manage scientific data.

By John Russell

Sept. 5, 2008 | Turning Semantic Web technology into practical applications that enhance biomedical research was a driving force behind Robert Stanley’s and Erich Gombocz’s collaboration long before they founded IO Informatics. The explosion of data and the scientific literature convinced them that effective data management and data integration were critical for productive data analysis.

While many people recognized the same challenges and opportunities, Stanley and Gombocz were among the few who adopted semantic web ideas early and worked to incorporate them deeply into a scientific data management platform—Sentient Suite. Semantic software applications use the “RDF” (Resource Description Framework) data model to enhance life science researchers’ ability to understand how data fit together in complex biological systems (see, “Building a Google for Bioinformatics,” Bio-IT World, July 2007).

“We were looking ten years ago, right when RDF was starting to come out, at how we could solve these general problems and came up with our own semantic data model,” says Stanley. “We were thrilled when [Sir Tim] Berners-Lee and the rest of the [World Wide Web Consortium] started pushing this semantic data model because we knew we were right on target.”

It’s a decade since Stanley (CEO) and Gombocz (CSO) first met. Stanley was working on a business plan and interviewing potential CEOs. One candidate said, “I’d consider coming and working with you but you’ve got to let me bring Erich.” The two hit it off immediately. Jettisoning the would-be CEO, Stanley and Gombocz founded Biosentients in 2000 to hold the intellectual property (IP) they were developing. In 2003, the team offered the IP, business plan, and emerging software to the investment community, and Biosentients became IO Informatics. Stanley was elevated to CEO in April 2007.

Today, IO Informatics has a growing staff of 20 in North America and Europe, with roughly 30 customers and “hundreds of users”—not eye-popping numbers but indicative of strengthening market traction.

In broad terms, the Sentient Suite is comprised of five components: a Data Manager, a Process Manager, Web Query, Knowledge Explorer, and Image Interactor. The Sentient Data Manager module is the heart of the suite. It automates data loading and acts as a data repository. The Process Manager can be thought of as a widely generalizable LIMS system with workflow capability. IO Informatics’ patented intelligent multi-dimensional object technology powers both. “These basic features turn data from any source into web-accessible, searchable, annotatable, HIPAA-compliant items and allow end-users to pick data subsets and identify data networks from them,” says Stanley. The query and analytics tools are integrated with the Data Manager and Process Manager. Stanley has leveraged the company’s image-handling expertise as image analysis software sold to Berlex and Washington University, St. Louis.

“The Web Query and Knowledge Explorer then make this data easily and usefully available in various formats,” says Stanley. “Virtually any researcher or manager derives both knowledge and efficiency benefits by using the Web Query to search and browse data and dashboards derived from federated data and to export results to their own applications,” such as Partek or Spotfire. Informaticians can apply the Knowledge Explorer to visualize integrated networks and run semantic queries. This could help characterize a drug’s activities, stratify tumor types based on biomarkers, using SPARQL and advanced semantic query languages.

_________________________________________________ 

This article appeared in Bio-IT World Magazine.

Subscriptions are free for qualifying individuals.  Apply Today.

 

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .